Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer�s disease. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company is also focusing on Huntington�s and Parkinson�s diseases. Other potential applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease and age-related cataracts.